These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation. Tu Z; Xu J; Jones LA; Li S; Mach RH Nucl Med Biol; 2010 May; 37(4):509-16. PubMed ID: 20447563 [TBL] [Abstract][Full Text] [Related]
46. High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. Nabulsi N; Huang Y; Weinzimmer D; Ropchan J; Frost JJ; McCarthy T; Carson RE; Ding YS Nucl Med Biol; 2010 Feb; 37(2):205-14. PubMed ID: 20152720 [TBL] [Abstract][Full Text] [Related]
47. ¹¹C-labeled analogs of indomethacin esters and amides for brain cyclooxygenase-2 imaging: radiosynthesis, in vitro evaluation and in vivo characteristics in mice. Yamamoto Y; Toyohara J; Ishiwata K; Sano K; Yamamoto F; Mukai T; Maeda M Chem Pharm Bull (Tokyo); 2011; 59(8):938-46. PubMed ID: 21804236 [TBL] [Abstract][Full Text] [Related]
48. 4-(((4-Iodophenyl)methyl)-4H-1,2,4-triazol-4-ylamino)-benzonitrile: A Potential Imaging Agent for Aromatase. Song J; Wu Z; Wangtrakuldee B; Choi SR; Zha Z; Ploessl K; Mach RH; Kung H J Med Chem; 2016 Oct; 59(20):9370-9380. PubMed ID: 27690428 [TBL] [Abstract][Full Text] [Related]
49. 3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [ Shrestha S; Singh P; Cortes-Salva MY; Jenko KJ; Ikawa M; Kim MJ; Kobayashi M; Morse CL; Gladding RL; Liow JS; Zoghbi SS; Fujita M; Innis RB; Pike VW ACS Chem Neurosci; 2018 Nov; 9(11):2620-2627. PubMed ID: 29792035 [TBL] [Abstract][Full Text] [Related]
50. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893 [TBL] [Abstract][Full Text] [Related]
51. Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animals. Sandiego CM; Jin X; Mulnix T; Fowles K; Labaree D; Ropchan J; Huang Y; Cosgrove K; Castner SA; Williams GV; Wells L; Rabiner EA; Carson RE J Nucl Med; 2013 Nov; 54(11):1962-8. PubMed ID: 24115528 [TBL] [Abstract][Full Text] [Related]
52. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters. Jarkas N; Votaw JR; Voll RJ; Williams L; Camp VM; Owens MJ; Purselle DC; Bremner JD; Kilts CD; Nemeroff CB; Goodman MM Nucl Med Biol; 2005 Apr; 32(3):211-24. PubMed ID: 15820756 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET. McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853 [TBL] [Abstract][Full Text] [Related]
54. Alteration in [11C]vorozole binding to aromatase in neuronal cells of rat brain induced by anabolic androgenic steroids and flutamide. Takahashi K; Tamura Y; Watanabe Y; Långström B; Bergström M Neuroreport; 2008 Mar; 19(4):431-5. PubMed ID: 18287941 [TBL] [Abstract][Full Text] [Related]
55. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β. Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging. Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688 [TBL] [Abstract][Full Text] [Related]
57. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET. Jarkas N; Voll RJ; Williams L; Goodman MM Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164 [TBL] [Abstract][Full Text] [Related]
58. In vivo visualization of aromatase in animals and humans. Biegon A Front Neuroendocrinol; 2016 Jan; 40():42-51. PubMed ID: 26456904 [TBL] [Abstract][Full Text] [Related]
59. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey. Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735 [TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors. Tsujikawa T; Zoghbi SS; Hong J; Donohue SR; Jenko KJ; Gladding RL; Halldin C; Pike VW; Innis RB; Fujita M Neuroimage; 2014 Jan; 84():733-41. PubMed ID: 24076222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]